Literature DB >> 725832

Reversibility of airways obstruction in bronchiectasis.

S G Nogrady, W V Evans, B H Davies.   

Abstract

Patients with airways obstruction and bronchiectasis were investigated for features of allergic disease and for reversibility of airways obstruction in respinse to inhaled and intravenous salbutamol. There was a 26% increase in PEFR and a 16% increase in FEV1 after inhaled salbutamol, and the response to the intravenous drug was not significantly better than that to the inhaled. Those patients who responded to bronchodilators could not be identified by clinical or immunological features.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 725832      PMCID： PMC470949          DOI： 10.1136/thx.33.5.635

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS.

Authors:  N G SANERKIN; D M EVANS
Journal:  J Pathol Bacteriol       Date:  1965-04

2.  Forced expiratory volume before and after isoprenaline.

Authors:  K M HUME; B GANDEVIA
Journal:  Thorax       Date:  1957-09       Impact factor: 9.139

3.  Pulmonary ventilation and gas exchange in bronchiectasis.

Authors:  J N Pande; B P Jain; R G Gupta; J S Guleria
Journal:  Thorax       Date:  1971-11       Impact factor: 9.139

4.  Factors associated with respiratory insufficiency in bronchiectasis.

Authors:  N S Cherniack; R W Carton
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965
  4 in total
  8 in total

1.  Bronchiectasis, congenital and acquired.

Authors: 
Journal:  Br Med J       Date:  1979-05-26

2.  Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis.

Authors:  Miguel Ángel Martínez-García; Grace Oscullo; Alberto García-Ortega; Maria Gabriella Matera; Paola Rogliani; Mario Cazzola
Journal:  Drugs       Date:  2021-11-26       Impact factor: 9.546

3.  Atopy, immunological changes, and respiratory function in bronchiectasis.

Authors:  M B Murphy; D J Reen; M X Fitzgerald
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

4.  Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline.

Authors:  Ho Jung Jeong; Hyun Lee; Keumhee C Carriere; Jung Hoon Kim; Jin-Hyung Han; Beomsu Shin; Byeong-Ho Jeong; Won-Jung Koh; O Jung Kwon; Hye Yun Park
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-07

5.  The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Authors:  Hamdan Al-Jahdali; Abdullah Alshimemeri; Abdullah Mobeireek; Amr S Albanna; Nehad N Al Shirawi; Siraj Wali; Khaled Alkattan; Abdulrahman A Alrajhi; Khalid Mobaireek; Hassan S Alorainy; Mohamed S Al-Hajjaj; Anne B Chang; Stefano Aliberti
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

Review 6.  Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019.

Authors:  Kevin Gruffydd-Jones; Duncan Keeley; Vikki Knowles; Ximena Recabarren; Alex Woodward; Anita L Sullivan; Michael R Loebinger; Karen Payne; Alex Harvey; Lizzie Grillo; Sally A Welham; Adam T Hill
Journal:  NPJ Prim Care Respir Med       Date:  2019-06-27       Impact factor: 2.871

7.  The Prevalence of Bronchodilator Responsiveness "Asthma" Among Adult Indigenous Australians Referred for Lung Function Testing in the Top End Northern Territory of Australia.

Authors:  Subash S Heraganahally; Timothy P Howarth; Angus Lloyd; Elisha White; Antony Veale; Helmi Ben Saad
Journal:  J Asthma Allergy       Date:  2022-09-14

8.  Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis.

Authors:  Antonello Nicolini; Federica Cardini; Norma Landucci; Sergio Lanata; Maura Ferrari-Bravo; Cornelius Barlascini
Journal:  BMC Pulm Med       Date:  2013-04-04       Impact factor: 3.317
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.